» Articles » PMID: 17405941

Update in Cystic Fibrosis 2006

Overview
Specialty Critical Care
Date 2007 Apr 5
PMID 17405941
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D) (Pre-D trial) in adults with....

Sivapiromrat A, Suppakitjanusant P, Wang Y, Hu C, Binongo J, Hunt W Contemp Clin Trials Commun. 2024; 38:101278.

PMID: 38435430 PMC: 10904905. DOI: 10.1016/j.conctc.2024.101278.


Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 × 2 trial of administration of prebiotics and cholecalciferol (vitamin D) (Pre-D Trial) in adults with....

Sivapiromrat A, Suppakitjanusant P, Wang Y, Binongo J, Hunt W, Gewirtz A medRxiv. 2024; .

PMID: 38343811 PMC: 10854319. DOI: 10.1101/2024.01.04.24300860.


Inhaled mannitol for cystic fibrosis.

Nevitt S, Thornton J, Murray C, Dwyer T Cochrane Database Syst Rev. 2020; 5:CD008649.

PMID: 32358807 PMC: 7195814. DOI: 10.1002/14651858.CD008649.pub4.


Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.

Ahmed M, Mukherjee S Cochrane Database Syst Rev. 2018; 7:CD011581.

PMID: 30052271 PMC: 6513196. DOI: 10.1002/14651858.CD011581.pub3.


Inhaled mannitol for cystic fibrosis.

Nevitt S, Thornton J, Murray C, Dwyer T Cochrane Database Syst Rev. 2018; 2:CD008649.

PMID: 29424930 PMC: 6491147. DOI: 10.1002/14651858.CD008649.pub3.


References
1.
Goss C, Rubenfeld G, Ramsey B, Aitken M . Clinical trial participants compared with nonparticipants in cystic fibrosis. Am J Respir Crit Care Med. 2005; 173(1):98-104. PMC: 2662984. DOI: 10.1164/rccm.200502-273OC. View

2.
Goss C, Mayer-Hamblett N, Kronmal R, Williams J, Ramsey B . Laboratory parameter profiles among patients with cystic fibrosis. J Cyst Fibros. 2006; 6(2):117-23. DOI: 10.1016/j.jcf.2006.05.012. View

3.
Elkins M, Robinson M, Rose B, Harbour C, Moriarty C, Marks G . A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006; 354(3):229-40. DOI: 10.1056/NEJMoa043900. View

4.
Donaldson S, Bennett W, Zeman K, Knowles M, Tarran R, Boucher R . Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006; 354(3):241-50. DOI: 10.1056/NEJMoa043891. View

5.
van Heeckeren A, Schluchter M, Xue W, Davis P . Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice. Am J Respir Crit Care Med. 2005; 173(3):288-96. PMC: 2662931. DOI: 10.1164/rccm.200506-917OC. View